Compare Organon & Co. Common Stock (OGN) vs Sirius XM Holdings Inc (SIRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon & Co. Common Stock vs Sirius XM Holdings Inc — how do they compare? Organon & Co. Common Stock trades at $13.73 (market cap $3.61B), while Sirius XM Holdings Inc trades at $26.42 (market cap $8.94B). The key difference: Sirius XM Holdings Inc is far larger — about 2.5× Organon & Co. Common Stock's market cap, and Sirius XM Holdings Inc pays the higher dividend (4.07%). Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and Sirius XM Holdings Inc for 103 Days on average.
| OGN | SIRI | |
|---|---|---|
Market Cap | $3.61B | $8.94B |
Volume | 1,808,049 | 2,400,454 |
Sector | Health | Media |
52-Week High | $13.81 | $32.59 |
52-Week Low | $5.70 | $19.92 |
Typical Hold Time | 0 Days | 103 Days |
Enterprise Value | $11.03B | $18.22B |
Dividend Yield | 0.58% | 4.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Sirius XM (SIRI) trades at $26.57, down slightly by 0.15% today, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net income margin of 10.23% for 2025, with revenue of $8.56B, and maintains a dividend payout. Recent news highlights a 53% YTD stock surge and positive analyst upgrades driven by advertising growth and a strategic YouTube partnership.
The outlook is cautiously optimistic, supported by strong analyst buy ratings (62.5%) and a consensus price target of $34.43, implying significant upside. Key risks include recent earnings misses, high debt levels, and competitive pressures in the media sector. Cash flow trends show improvement, with net cash flow turning positive in 2026 projections.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →About Sirius XM Holdings Inc
SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →
